Loading company…
ONK Therapeutics develops engineered natural killer cell therapies for solid and blood cancers.
Founded in 2015 and based in Galway, Ireland, ONK Therapeutics develops off-the-shelf natural killer cell therapies for solid and hematological cancers. Its engineering approach aims to improve tumor targeting and cell persistence. In January 2022, it raised USD 21.5 mn in Series A funding from investors including ALSHC and Acorn BioVentures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in